| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $57.6M | -2.8% | -19.1% |
| R&D Expense | $14.8M | +4.2% | -11.0% |
| SG&A Expense | $12.1M | +6.3% | +4.1% |
| Operating Income | -$7.9M | -125.6% | -64.6% |
| Pre-tax Income | -$8.8M | -222.2% | -143.0% |
| Income Tax | $294K | +40.7% | +155.1% |
| Net Income | -$9.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $106.3M | -5.8% | +1.1% |
| Accounts Receivable | $23.6M | -4.1% | -17.0% |
| Current Assets | $138.5M | -8.3% | -4.0% |
| Total Assets | $299.2M | -5.4% | -9.5% |
| Current Liabilities | $35.5M | -14.4% | +2.2% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $22.6M | — | — |
| Capital Expenditures | $837K | — | — |
| Investing Cash Flow | -$12.7M | — | — |
| Financing Cash Flow | -$14.5M | — | — |
| Free Cash Flow | $21.8M | — | — |
| -209.3% |
| -194.4% |
| EPS (Basic) | -$0.07 | -250.0% | -250.0% |
| EPS (Diluted) | -$0.07 | -250.0% | -250.0% |
| $60.2M |
| -15.1% |
| -7.9% |
| Stockholders' Equity | $238.9M | -2.6% | -9.9% |